Firm Unveils New Drug to Tackle Heart Diseases

Sandoz, a global generics company that is a significant part of the Novartis group, has unveiled a new drug targeted at managing heart failure and controlling blood pressure.

Novartris unveiled the ‘Candesartan Sandoz’ drug recently in Lagos, with the aim of allowing millions access affordable medications without compromising product quality at a much reduced cost.

Speaking at the launch, the Country Head, Novartis, Mr. Adepeju Idowu said: “We are introducing   Candesartan Sandoz to address the unmet need in the management of cardiovascular disease particularly Hypertension, Left  ventricular hypertrophy (LVH) and the Heart failure. Sandoz, as at today is the number two biggest generic business in the world worth more than $10 billion. And we are committed to bring out quality medications.”

He also added that treatment with Candesartan reduces mortality and hospitalisation due to heart failure and improves symptoms in patients with left ventricular systolic dysfunction.

Read more here

Share this article:
join our mailing list

Do you want more articles like this delivered to your inbox?

Join our mailing list to receive the latest news and articles.

PS: Your email WILL NOT BE SPAMMED. See our Privavcy Policy for detail.

Thank you for subscribing. You are now part of our mailing list.

Show/Hide Comments

0 thoughts on “Firm Unveils New Drug to Tackle Heart Diseases

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

join our mailing list


Get all the latest and most popular news, tips, articles and information from our website delivered straight into your inbox.

Thank you for subscribing to our mailing list. You will now start recieving our periodic newsletter.

Powered byRapidology